Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Targeted gene transfer into head and neck squamous cell carcinoma by nanosecond pulsed laser-induced stress waves.

Araki K, Mizokami D, Tanaka N, Suzuki H, Sato S, Shiotani A.

Lasers Med Sci. 2014 Jan;29(1):231-8. doi: 10.1007/s10103-013-1324-3. Epub 2013 Apr 24.

PMID:
23613091
2.

Synergistic antitumor effect of AAV-mediated TRAIL expression combined with cisplatin on head and neck squamous cell carcinoma.

Jiang M, Liu Z, Xiang Y, Ma H, Liu S, Liu Y, Zheng D.

BMC Cancer. 2011 Feb 3;11:54. doi: 10.1186/1471-2407-11-54.

3.
4.

The role of adenovirus-mediated retinoblastoma 94 in the treatment of head and neck cancer.

Li D, Day KV, Yu S, Shi G, Liu S, Guo M, Xu Y, Sreedharan S, O'Malley BW Jr.

Cancer Res. 2002 Aug 15;62(16):4637-44.

5.

Novel adenoviral gene delivery system targeted against head and neck cancer.

Li D, Guang W, Abuzeid WM, Roy S, Gao GP, Sauk JJ, O'Malley BW Jr.

Laryngoscope. 2008 Apr;118(4):650-8. doi: 10.1097/MLG.0b013e3181613aba.

PMID:
18176343
6.

Targeted gene transfer into rat facial muscles by nanosecond pulsed laser-induced stress waves.

Kurita A, Matsunobu T, Satoh Y, Ando T, Sato S, Obara M, Shiotani A.

J Biomed Opt. 2011 Sep;16(9):098002. doi: 10.1117/1.3628313.

PMID:
21950944
7.

Eradication of p53-mutated head and neck squamous cell carcinoma xenografts using nonviral p53 gene therapy and photochemical internalization.

Ndoye A, Dolivet G, Høgset A, Leroux A, Fifre A, Erbacher P, Berg K, Behr JP, Guillemin F, Merlin JL.

Mol Ther. 2006 Jun;13(6):1156-62. Epub 2006 Mar 27.

8.

Head and neck squamous cell carcinoma targeted chemosensitization.

Figures MR, Wobb J, Araki K, Liu T, Xu L, Zhu H, O'Malley BW Jr, Li D.

Otolaryngol Head Neck Surg. 2009 Aug;141(2):177-83. doi: 10.1016/j.otohns.2009.04.024.

PMID:
19643248
9.

FasL gene therapy: a new therapeutic modality for head and neck cancer.

ElOjeimy S, McKillop JC, El-Zawahry AM, Holman DH, Liu X, Schwartz DA, Day TA, Dong JY, Norris JS.

Cancer Gene Ther. 2006 Aug;13(8):739-45. Epub 2006 Mar 17.

PMID:
16543918
10.

Gene transfer into mammalian cells by use of a nanosecond pulsed laser-induced stress wave.

Terakawa M, Ogura M, Sato S, Wakisaka H, Ashida H, Uenoyama M, Masaki Y, Obara M.

Opt Lett. 2004 Jun 1;29(11):1227-9. Erratum in: Opt Lett. 2004 Sep 15;29(18):2190.

PMID:
15209255
11.

Role of squamous cell carcinoma antigen 1 expression in the invasive potential of head and neck squamous cell carcinoma.

Nakashima T, Yasumatsu R, Kuratomi Y, Masuda M, Kuwano T, Toh S, Umezaki T, Cataltepe S, Silverman GA, Komune S.

Head Neck. 2006 Jan;28(1):24-30.

PMID:
16155915
12.

Sustained transgene expression in intervertebral disc cells in vivo mediated by microbubble-enhanced ultrasound gene therapy.

Nishida K, Doita M, Takada T, Kakutani K, Miyamoto H, Shimomura T, Maeno K, Kurosaka M.

Spine (Phila Pa 1976). 2006 Jun 1;31(13):1415-9.

PMID:
16741448
13.

Targeted DNA transfection into the mouse central nervous system using laser-induced stress waves.

Satoh Y, Kanda Y, Terakawa M, Obara M, Mizuno K, Watanabe Y, Endo S, Ooigawa H, Nawashiro H, Sato S, Takishima K.

J Biomed Opt. 2005 Nov-Dec;10(6):060501.

PMID:
16409064
14.

Sendai virus-mediated gene transfer of the c-myc suppressor far-upstream element-binding protein-interacting repressor suppresses head and neck cancer.

Tanaka N, Araki K, Mizokami D, Miyagawa Y, Yamashita T, Tomifuji M, Ueda Y, Inoue M, Matsushita K, Nomura F, Shimada H, Shiotani A.

Gene Ther. 2015 Apr;22(4):297-304. doi: 10.1038/gt.2014.123. Epub 2015 Jan 15.

PMID:
25588744
15.

In vitro studies of liposome-mediated gene transfer into head and neck cancer cell lines.

Wollenberg B, Lang S, Schmitt B, Kastenbauer E, Zeidler R.

Eur Arch Otorhinolaryngol. 1997;254 Suppl 1:S130-2.

PMID:
9065647
16.

Fas ligand gene transfer effectively induces apoptosis in head and neck cancer cells.

Ji X, Jiang C, Liu Y, Bu D, Xiao S.

Acta Otolaryngol. 2011 Aug;131(8):876-81. doi: 10.3109/00016489.2011.562539. Epub 2011 Apr 19.

PMID:
21504271
17.
18.

Interleukin-21 triggers both cellular and humoral immune responses leading to therapeutic antitumor effects against head and neck squamous cell carcinoma.

Nakano H, Kishida T, Asada H, Shin-Ya M, Shinomiya T, Imanishi J, Shimada T, Nakai S, Takeuchi M, Hisa Y, Mazda O.

J Gene Med. 2006 Jan;8(1):90-9.

PMID:
16097036
20.

TGF-alpha antisense gene therapy inhibits head and neck squamous cell carcinoma growth in vivo.

Endo S, Zeng Q, Burke NA, He Y, Melhem MF, Watkins SF, Lango MN, Drenning SD, Huang L, Rubin Grandis J.

Gene Ther. 2000 Nov;7(22):1906-14.

Supplemental Content

Support Center